Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 8;11:7537–7556. doi: 10.2147/CMAR.S181439

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Saavedra et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Symptomatic assessment tools. The figure collects the different tools employed to evaluated quality of life in studies and trials of neuroendocrine tumors.

Abbreviations: BDI-II, Beck Depression Inventory-II; HADs, Hospital Anxiety and Depression Scale; CES-D, Center for Epidemiologic Studies Depression; STAI Y1/2, State-Trait Anxiety Inventory Fonn Y; PAIS, Psychological Adjustment to Illness Scale; LOT, Life Orientation Test; iES, Impact of Event Scale; FACIT-D, Functional Assessment of Chronic Illness Therapy-Diarrhea; FACIT-Fatigue, Functional Assessment of Chronic Illness Therapy-Fatigue; QSD, Questionnaire for screening Sexual Dysfunction; CSSS, Carcinoid Symptom Severity Score; EORTC QLQ-GINET.21, European Organisation for Research and Treatment of Cancer Quality of life Questionnaire – Gastrointestinal Neuroendocrine Tumors; Norfolk QLQ-NET, Norfolk Quality of life Questionnaire for Neuroendocrine Tumors; EQ-5D, Euro-Quality of Life instrument; PROMIS-29, PRO measurement information system; GHQ-12, 12-item General Health Questionnaire; GHQ-30, 30-item General Health Questionnaire; SF-12, 12-item Short-Form Health Survey. SF-36: 36-item Short-Fonn Health Survey; VAS, Visual Analogue Scale for Quality of Life; EORTC QLO-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30; FACT-G, Functional Assessment of Cancer Therapy-General.